Teva Divests Takeda JV, Pivots To Innovative Drugs In Japan
Takeda Expects $365m Payment
The divestment decision comes years after it slimmed down amid challenges in the Japanese generic market.
The divestment decision comes years after it slimmed down amid challenges in the Japanese generic market.